Anti-UHRF1 抗体 [EPR18803]
Anti-UHRF1 antibody [EPR18803]
- RabMAb
- Recombinant
- 詳細を見る
3
(2 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal UHRF1 antibody. Suitable for IP, WB, IHC-P and reacts with Human, Rat samples. Cited in 7 publications.
別名を表示する
ICBP90, NP95, RNF106, UHRF1, E3 ubiquitin-protein ligase UHRF1, Inverted CCAAT box-binding protein of 90 kDa, Nuclear zinc finger protein Np95, RING finger protein 106, Transcription factor ICBP90, Ubiquitin-like PHD and RING finger domain-containing protein 1, HuNp95, Nuclear protein 95, hNp95, hUHRF1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UHRF1 antibody [EPR18803] (AB194236)
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling UHRF1 with ab194236 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nucleus staining on lymphocytes of Human tonsil is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UHRF1 antibody [EPR18803] (AB194236)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling UHRF1 with ab194236 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nucleus staining on the epithelial cells of Human colon is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-UHRF1 antibody [EPR18803] (AB194236)
UHRF1 was immunoprecipitated from 1mg of HepG2 (Human liver hepatocellular carcinoma) whole cell lysate with ab194236 at 1/20 dilution.
Western blot was performed from the immunoprecipitate using ab194236 at 1/1000 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : HepG2 whole cell lysate 10ug (Input).
Lane 2 : ab194236 IP in HepG2 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab194236 in HepG2 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-UHRF1 antibody [EPR18803] (ab194236)
Predicted band size: 89 kDa
Observed band size: 97 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-UHRF1 antibody [EPR18803] (AB194236)
Immunohistochemical analysis of paraffin-embedded Rat spleen tissue labeling UHRF1 with ab194236 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Nucleus staining on lymphocytes of rat spleen is observed.
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-UHRF1 antibody [EPR18803] (AB194236)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : Lane 1 and 2 : 10 seconds; Lane 3 : 3 minutes.
The molecular weight observed is consistent with what has been described in the literature (PMID : 12530060).
All lanes:
Western blot - Anti-UHRF1 antibody [EPR18803] (ab194236) at 1/5000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg
Lane 3:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 89 kDa
Observed band size: 97 kDa
false
- WB
Lab
Western blot - Anti-UHRF1 antibody [EPR18803] (AB194236)
Blocking and diluting buffer and concentration : 5% NFDM /TBST. UHRF1 has two isoforms. UHRF1 undergo degradation under normal conditions as well as in response to DNA damage. (PMID : 23297342, PMID : 36593255)
All lanes:
Western blot - Anti-UHRF1 antibody [EPR18803] (ab194236) at 1/1000 dilution
Lane 1:
Human colon tissue lysate at 20 µg
Lane 2:
Human breast tissue lysate at 20 µg
Lane 3:
Human thymus tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution
Predicted band size: 89 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-UHRF1 antibody [EPR18803] (AB194236)
Blocking and diluting buffer and concentration : 5% NFDM /TBST. ab181602 was used as GAPDH loading control. UHRF1 has two isoforms. UHRF1 undergo degradation under normal conditions as well as in response to DNA damage. (PMID : 23297342, PMID : 36593255)
All lanes:
Western blot - Anti-UHRF1 antibody [EPR18803] (ab194236) at 1/1000 dilution
Lane 1:
Human brain tissue lysate at 20 µg
Lane 2:
Human kidney tissue lysate at 20 µg
Lane 3:
Human spleen tissue lysate at 20 µg
Lane 4:
Human colon tissue lysate at 20 µg
Lane 5:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
U-937 (Human histiocytic lymphoma monocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution
Predicted band size: 89 kDa
false
Exposure time: 20s
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-UHRF1 antibody [EPR18803] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UHRF1 engages in preserving the DNA methylation landscape ensuring proper gene expression patterns. It is part of a multi-protein complex and processes both histone modification and DNA methylation. Its presence is critical for gene silencing through the recruitment of DNMT1 and histone deacetylases. UHRF1 therefore influences regulatory regions of genes important for cell cycle progression and development.
Pathways
UHRF1 integrates into methylation-dependent gene silencing and cell cycle regulation. It actively participates in DNA damage repair pathways by modulating the p53 pathway aiding cell survival post-DNA damage. UHRF1 closely interacts with epigenetic regulators such as DNMT1 and histone deacetylases bridging methylation and chromatin remodeling to ensure proper cell cycle and transcriptional control.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (7)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research : CR 44:13 PubMed39810240
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology 12: PubMed37626981
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:112823 PubMed37463106
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 18:20230650 PubMed36865496
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 132: PubMed35472067
2022
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 2055:521-562 PubMed31502168
2019
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 8:1086-1096 PubMed35116851
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com